targeted markets Position Celerus diagnostics as a specialized, fast IHC staining solution for mid-sized pathology laboratories and hospital systems seeking rapid intraoperative and frozen section diagnostics to improve turnaround times and patient care.

workflow efficiency Leverage the Wave and Wave RPD capabilities to highlight cost savings and labor efficiency from fully automated, end-to-end IHC staining, enabling labs to repurpose or reallocate personnel and reduce bottlenecks.

clinical impact emphasize faster actionable results (15 minutes on certain workflows; 75 minutes for automated staining) to support clinicians with timely treatment decisions and potential for improved patient outcomes.

partnership target opportunities with mid-to-large pathology groups and hospital networks that require scalable, high-throughput IHC platforms, offering integration potential with existing cloud and IT infrastructure (AWS, CDN, DNS, AMP) for data management and reporting.

growth signals align with the broader diagnostic trend toward automation and rapid immunohistochemistry to position Celerus as a disruptor in intraoperative diagnostics, creating cross-sell avenues to adjacent labs and potential distribution partnerships with larger reference laboratories.